ANALYSIS OF PHARMACOLOGIC APPROACHES ABLE TO RESTORE RKIP FUNCTION IN HEPATOCELLULAR CARCINOMA
Poma P., Notarbartolo M., Labbozzetta M., Vivona N., D'Alessandro N. |
IDENTIFICATION OF DRUGS TARGETING LEUKEMIC STEM CELL (LSC) SIGNATURE GENES
Ferruzzi L., Mulaw M., Ihme S., Fimognari C., Buske C. |
LONG GLUCOCORTICOID-INDUCED LEUCINE ZIPPER (L-GILZ) ACTS AS A TUMOR SUPPRESSOR BY ACTIVATING P53
Petrillo M., Ayroldi E., Cannarile L., Marchetti M., Ronchetti S., Nocentini G., Riccardi C. |
NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE (NAMPT) INHIBITORS: NOVEL MODULATORS OF CANCER-RELATED INFLAMMATION
Travelli C., Morlacchi S., Sica A., Canonico P., Genazzani A. |
CHEMISTRY AND PHARMACOLOGICAL PROPERTIES OF TWO GOLD(I) CARBENE COMPLEXES AS POTENTIAL ANTICANCER AGENTS
Nobili S., Messori L., Marchetti L., Massai L., Scaletti F., Guerri A., Landini I., Perrone G., Mini E., Leoni P., Pasquali M., Gabbiani C. |
ON THE CARDIAC SAFETY OF PIXANTRONE IN DOXORUBICIN-TREATED PATIENTS: PHARMACOKINETIC AND METABOLIC CHARACTERIZATIONS IN AN EX VIVO HUMAN MYOCARDIAL STRIP MODEL
Salvatorelli E., Menna P., Minotti G. |
THE INTRACELLULAR DEATH PATHWAYS INVOLVED IN ZOLEDRONIC ACID-INDUCED APOPTOSIS OF HUMAN BREAST CANCER CELL LINES
Fragni M., Bodei S., Bonini S., Generali D., Bottini A., Spano P., Memo M., Sigala S. |
STRUCTURAL CHARACTERIZATION OF LUNG CANCER XENOGRAFTS FOR THE ASSESSMENT OF THE THERAPEUTIC EFFICACY OF EGFR TARGETING MOLECULES
Graiani G., Madeddu D., Gervasi A., Saccani F., Frati C., Cavalli S., Lagrasta C., Falco A., Facchinetti F., Alfieri R., Ampollini L., Lorusso B., Urbanek K., Petronini P., Quaini F. |
